Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related AXS
Earnings Scheduled For February 2, 2016
UPDATE: AXIS Capital Agrees to Terminate Merger with PartnerRe and Receives $315M Breakup Fee
Related THRX
Theravance Inc Reports Prelim Tender Offer Results
Glaxosmithkline, Theravance Intend to File Relvar Ellipta for COPD in Japan

Analysts at Goldman Sachs downgraded Axis Capital Holdings (NYSE: AXS) from “neutral” to “sell.” The target price for Axis Capital has been lowered from $44 to $43. Axis Capital's shares closed at $46.34 yesterday.

Stifel Nicolaus downgraded Theravance (NASDAQ: THRX) from “buy” to “hold” and removed the price target of $37.86. Theravance's shares closed at $26.40 yesterday.

Sterne Agee downgraded SpringLeaf Holdings (NYSE: LEAF) from “buy” to “neutral.” The target price for SpringLeaf has been lowered from $30 to $28. SpringLeaf's shares closed at $26.49 yesterday.

Analysts at KeyBanc downgraded Computer Programs and Systems (NASDAQ: CPSI) from “hold” to “underweight.” The price target for Computer Programs is set to $55. Computer Programs' shares closed at $65.70 yesterday.

Latest Ratings for AXS

DateFirmActionFromTo
Feb 2016CitigroupMaintainsNeutral
Feb 2016Deutsche BankMaintains
Jan 2016JMP SecuritiesDowngradesMarket OutperformMarket Perform

View More Analyst Ratings for AXS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CPSI + AXS)

Get Benzinga's Newsletters